A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing ...

The most important take-home information from the INTERLACE trial is that in some people with cervical cancer that are ...

Anixa Biosciences CEO Amit Kumar discusses the biotech’s plans for advancing a breast cancer vaccine in 2025. The cancer ...

As the year gets underway, analysts and biotech executives highlight cell therapy’s pivot from oncology to autoimmune ...

Prostate cancer presents challenges in detection, treatment, and management. Learn about genetic risks, treatment resistance, ...

Microbeam radiation therapy has proven effective in animal studies against tumours in the brain, breast, skin and central ...

OncoHost, a global leader in next-generation precision oncology dedicated to advancing personalized cancer therapy, announced today that it has been named a winner in the 2025 BIG Innovation Awards.

From groundbreaking immunotherapies to advanced targeted treatments, oncology is set to make historic strides in the year ahead.

The therapy, dubbed OST-HER2, uses a HER2-bioengineered form of the bacteria Listeria monocytogenes to trigger an immune ...

Immunotherapy is a modern approach to cancer treatment that uses a patient's own immune system to help fight tumors.

A new type of cell-based immunotherapy shows promise for B-cell lymphomas and - due to innovations in manufacturing - could make future cellular immunotherapies less expensive and more accessible to ...

Cancer is a disease of the genome, according to Dr. Elli Papaemmanuil, computational oncologist at MSK. By looking at the ...